Fangfang Zhu is the founder of HemaCell. HemaCell has raised $57M in total funding. Latest round: Series B. Based in Stanford, California, United States.
Fangfang Zhu is an Associate Professor at Stanford University and the founder of HemaCell Therapeutics, also known as Xue Ji Biotech/血霁生物. She founded the company in November 2020, focusing on stem cell therapies for thrombocytopenia and aging-related indications.
Full founder directory · Investor directory · Company funding database · Fundraising library